For these populations, the focus must remain solely on environmental avoidance and gentle, supportive nutrition until it is safe to begin detoxifying
The injectable obesity medications Semaglutide 2.4 mg, a selective GLP-1 receptor agonist, produces robust and durable weight loss of approximately 1516% over 68 weeks ( Tirzepatide, a dual gastric inhibitory polypeptide (GIP)/GLP-1 receptor agonist, delivers even greater weight loss, exceeding 20% at the highest dose in pivotal trials ( Retatrutide, a triple agonist targeting GIP, GLP-1, and glucagon receptors, represents a further step in efficacy, with 24.2% weight loss achieved within 48 weeks in phase 2 studies ( Survodutide, an oxyntomodulin analogue, achieved clinically meaningful weight loss ( Table 2
Konukoglu and Uzun, 2017)
Powder-free nitrile gloves and a disinfected flat workspace
When B12 is low, red blood cells become oversized and inefficient (megaloblastic anemia), and oxygen delivery to follicles drops